|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 This paper was completed while the author was the guest of Professor J. Einhorn, Director, Radiumhemmet, Karolinska Institutet, Stockholm, Sweden.
Sr87m localizes in childrens malignant soft tissue tumors with enough specificity to allow circumscribed visualization of the neoplasms on rectilinear scans.
In a series of 10 children with chest masses, increased uptake of Sr87m was apparent in all 7 malignant tumors. There was no visible abnormal uptake in 3 benign lesions or in 10 children without pulmonary disease.
Uptake of Sr87m into malignant soft tissue tumors is a newly discovered phenomenon which appears to be independent of the visualization of bone tumors with strontium isotopes. The mechanism of this uptake into malignant soft tissue tumors does not appear to be due to differential vascularity. It may be analogous to the recently described affinity of gallium isotopes for malignant tumors.
Sr87m scans are proposed as a screening test for hidden malignancy and for the differential diagnosis and spatial visualization of masses seen on roentgenograms, thereby facilitating radiation therapy.
Further investigation and exploitation of this new cancer diagnostic agent is encouraged.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |